Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience

A Matched Cohort Study of Patients With End-Stage Heart Failure from Anthracycline-Induced Cardiomyopathy Requiring Advanced Cardiac Support

(2016) Garry R. Thomas et al.   AMERICAN JOURNAL OF CARDIOLOGY

Prevention of cardiotoxicity among survivors of childhood cancer

(2016) Kelley K. Hutchins et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

(2016) Giuseppe Curigliano et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Therapy–Related Cardiac Dysfunction and Heart Failure

(2016) Carine E. Hamo et al.   Circulation-Heart Failure

Cancer Therapy–Related Cardiac Dysfunction and Heart Failure

(2016) Michelle W. Bloom et al.   Circulation-Heart Failure

The evolving field of cardio-oncology: beyond anthracyclines and heart failure: Table 1

(2016) Michael G. Fradley   EUROPEAN HEART JOURNAL

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

(2016) Yigal M. Pinto et al.   EUROPEAN HEART JOURNAL

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN HEART JOURNAL

Heart Failure Therapies for End-Stage Chemotherapy–Induced Cardiomyopathy

(2016) Roy B. Mukku et al.   JOURNAL OF CARDIAC FAILURE

Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies

(2016) James S. Ware et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Toxic Effects of Targeted Cancer Therapies

(2016) Javid J. Moslehi   NEW ENGLAND JOURNAL OF MEDICINE

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer

(2015) Gregory T. Armstrong et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2015) Roberto M. Lang et al.   European Heart Journal-Cardiovascular Imaging

Incidence, Predictors, and Impact on Survival of Left Ventricular Systolic Dysfunction and Recovery in Advanced Cancer Patients

(2014) Guilherme H. Oliveira et al.   AMERICAN JOURNAL OF CARDIOLOGY

Cancer treatment and survivorship statistics, 2014

(2014) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cardiomyopathy Associated With Cancer Therapy

(2014) Anthony F. Yu et al.   JOURNAL OF CARDIAC FAILURE

Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 Decades

(2013) Gabriele Castelli et al.   Circulation-Heart Failure

Heart Transplant Survival Outcomes for Adriamycin-Dilated Cardiomyopathy

(2012) Andrew J. Lenneman et al.   AMERICAN JOURNAL OF CARDIOLOGY

Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation

(2012) Guilherme H. Oliveira et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Projections of the Cost of Cancer Care in the United States: 2010-2020

(2011) A. B. Mariotto et al.   JNCI-Journal of the National Cancer Institute

Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy

(2010) Anne H. Blaes et al.   BREAST CANCER RESEARCH AND TREATMENT

Anthracycline-Induced Cardiomyopathy

(2010) Daniela Cardinale et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia

(2009) Perundurai S Dhandapany et al.   NATURE GENETICS